stockrowWarby Parker Inc.
WRBY Healthcare Medical Instruments & Supplies
Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024.
- Revenue
- +10.4%
- EPS
- −20.0%
- Free cash flow
- −30.3%
Quarter to September 2026, against a year earlier
Follow WRBY
Alert me
Warby Parker Inc. (WRBY) EV/FCF
As of 5 November 2026, Warby Parker Inc. (WRBY) trades at a EV/FCF of 139×. Over the past ten years it has ranged from −2,875× (July 2023) to 212× (February 2024); the current reading is higher than 93% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 54.6× | (28.80%) |
| FY2024 | 76.6× | (63.39%) |
| FY2023 | 209× | — |
| FY2022 | −28.9× | — |
| FY2021 | −38.0× | — |
| FY2020 | −197× | — |
| FY2019 | −197× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 149× | (6.42%) |
| Jun 2026 | 159× | 168.25% |
| Mar 2026 | 59.4× | 8.94% |
| Dec 2025 | 54.6× | (33.71%) |
| 22 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| STVN Stevanato Group S.p.A. compare | −453× |
| PLSE Pulse Biosciences, Inc compare | −17.8× |
| KMTS Kestra Medical Technologies, Ltd. compare | −12.3× |
| LMAT LeMaitre Vascular, Inc. compare | 25.1× |
| ICUI ICU Medical, Inc. compare | 25.5× |
| XRAY DENTSPLY SIRONA Inc. compare | 40.0× |
| ATRC AtriCure, Inc. compare | 125× |
| WRBY Warby Parker Inc. | 139× |
| AZTA Azenta, Inc. compare | 144× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on WRBY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement